{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:39:29Z","timestamp":1794955169984,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Backgroud<\/jats:title>\n                <jats:p>Cenegermin (Oxervate, Domp\u00e8 Farmaceutici, Milan, IT), a recombinant human NGF, is a potentially healing new drug for neurotrophic keratopathy (NK), a rare but challenging disease affecting the cornea. To date, studies that evaluate its mid-term effect on corneal nerves and sensitivity are lacking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate the recovery and morphology of subbasal corneal nerves in patients treated with Cenegermin for NK and assess their correlation with corneal sensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This prospective, observational case series study was carried out between May 2018 and August 2020 at the Ophthalmic Clinic of the University of Verona. Clinical evaluation, sensitivity, and in vivo confocal microscopy (IVCM) were performed in the central and all four corneal sectors at baseline, the end of therapy (8\u00a0weeks), and 2, 4, and 8\u00a0months after therapy. Consecutive patients with NK (stage 2\u20133), treated with Cenegermin (1 drop 6 times daily for 8\u00a0weeks), were enrolled. During each visit, Corneal nerve fiber length (CNFL), corneal nerve fiber total branch density (CTBD), corneal nerve fiber fractal dimension (CNFraD) and Cochet-Bonnet esthesiometry (CBE) were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We enrolled 18 patients. Complete NK healing was noted in 14\/18(78%) patients after 8\u00a0weeks of treatment; then in 14(78%), 15(83%), and 13(72%) patients at 2-, 4-, and 8-months, respectively. Starting at 8\u00a0weeks through 4-month follow-up there was progressive improvement in CBE in all corneal sectors (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.01), which continued thereafter. There was significant corneal nerve regrowth especially in the peripheral cornea: centripetal progression starting at 8\u00a0weeks (CNFL and CNFrad) and significant branching starting at 2\u00a0months (CTBD), which continued through to the end of follow up. Sector-coupled IVCM and CBE findings correlated at all evaluations (all r\u2009\u2265\u20090.62 starting at 2\u00a0months, with highest values in the peripheral sectors).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>After Cenegermin we observed a subbasal corneal nerve regeneration, a recovery of sensitivity and a lasting epithelial healing, suggesting that the effect of its action persists several months after discontinuation in patients with NK.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02237-5","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:10:51Z","timestamp":1645467051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy"],"prefix":"10.1186","volume":"17","author":[{"given":"Emilio","family":"Pedrotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Bonacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Chierego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"De Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-2379","authenticated-orcid":false,"given":"Tiziano","family":"Cozzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Brighenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Caldarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanlorenzo","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Fasolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"2237_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.04.003","volume":"66","author":"HS Dua","year":"2018","unstructured":"Dua HS, Said DG, Messmer EM, Rolando M, Benitez-Del-Castillo JM, Hossain PN, et al. Neurotrophic keratopathy. Prog Retin Eye Res. 2018;66:107\u201331.","journal-title":"Prog Retin Eye Res"},{"key":"2237_CR2","first-page":"571","volume":"8","author":"M Sacchetti","year":"2014","unstructured":"Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571\u20139.","journal-title":"Clin Ophthalmol"},{"issue":"7\u20138","key":"2237_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/08820538.2019.1648692","volume":"34","author":"N Wolkow","year":"2019","unstructured":"Wolkow N, Habib LA, Yoon MK, Freitag SK. Corneal neurotization: review of a new surgical approach and its developments. Semin Ophthalmol. 2019;34(7\u20138):473\u201387.","journal-title":"Semin Ophthalmol"},{"issue":"9","key":"2237_CR4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.ophtha.2018.03.004","volume":"125","author":"S Bonini","year":"2018","unstructured":"Bonini S, Lambiase A, Rama P, Filatori I, Allegretti M, Chao W, et al. Phase I trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125(9):1468\u201371.","journal-title":"Ophthalmology"},{"issue":"9","key":"2237_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","volume":"125","author":"S Bonini","year":"2018","unstructured":"Bonini S, Lambiase A, Rama P, Sinigaglia F, Allegretti M, Chao W, et al. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125(9):1332\u201343.","journal-title":"Ophthalmology"},{"key":"2237_CR6","doi-asserted-by":"crossref","unstructured":"Ting DSJ. Re: Bonini et al.: phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2019;126(2):e14-5.","DOI":"10.1016\/j.ophtha.2018.09.017"},{"key":"2237_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajo.2020.04.036","volume":"217","author":"L Mastropasqua","year":"2020","unstructured":"Mastropasqua L, Lanzini M, Dua HS, Duffizi A, Di Nicola M, Calienno R, et al. In\u00a0vivo evaluation of corneal nerves and epithelial healing after treatment with recombinant nerve growth factor for neurotrophic keratopathy. Am J Ophthalmol. 2020;217:278\u201386.","journal-title":"Am J Ophthalmol"},{"key":"2237_CR8","first-page":"506","volume-title":"Current ocular therapy","author":"I Mackie","year":"1995","unstructured":"Mackie I, Fraunfelder F. Current ocular therapy. 4th ed. Philadelphia: WB Saunders; 1995. p. 506\u20138.","edition":"4"},{"issue":"4","key":"2237_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1109\/TBME.2016.2573642","volume":"64","author":"X Chen","year":"2017","unstructured":"Chen X, Graham J, Dabbah MA, Petropoulos IN, Tavakoli M, Malik RA. An automatic tool for quantification of nerve fibers in corneal confocal microscopy images. IEEE Trans Biomed Eng. 2017;64(4):786\u201394.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"4","key":"2237_CR10","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1167\/iovs.13-13787","volume":"55","author":"IN Petropoulos","year":"2014","unstructured":"Petropoulos IN, Alam U, Fadavi H, Marshall A, Asghar O, Dabbah MA, et al. Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy. Invest Ophthalmol Vis Sci. 2014;55(4):2071\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"2237_CR11","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1097\/ICO.0b013e3182749419","volume":"32","author":"IN Petropoulos","year":"2013","unstructured":"Petropoulos IN, Manzoor T, Morgan P, Fadavi H, Asghar O, Alam U, et al. Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology. Cornea. 2013;32(5):e83-89.","journal-title":"Cornea"},{"issue":"5","key":"2237_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.media.2011.05.016","volume":"15","author":"MA Dabbah","year":"2011","unstructured":"Dabbah MA, Graham J, Petropoulos IN, Tavakoli M, Malik RA. Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging. Med Image Anal. 2011;15(5):738\u201347.","journal-title":"Med Image Anal"},{"issue":"Pt 1","key":"2237_CR13","first-page":"300","volume":"13","author":"MA Dabbah","year":"2010","unstructured":"Dabbah MA, Graham J, Petropoulos I, Tavakoli M, Malik RA. Dual-model automatic detection of nerve-fibres in corneal confocal microscopy images. Med Image Comput Comput Assist Interv. 2010;13(Pt 1):300\u20137.","journal-title":"Med Image Comput Comput Assist Interv"},{"issue":"6","key":"2237_CR14","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.2337\/dc14-2422","volume":"38","author":"X Chen","year":"2015","unstructured":"Chen X, Graham J, Dabbah MA, Petropoulos IN, Ponirakis G, Asghar O, et al. Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care. 2015;38(6):1138\u201344.","journal-title":"Diabetes Care"},{"issue":"5","key":"2237_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2337\/dc14-2311","volume":"38","author":"M Tavakoli","year":"2015","unstructured":"Tavakoli M, Ferdousi M, Petropoulos IN, Morris J, Pritchard N, Zhivov A, et al. Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set. Diabetes Care. 2015;38(5):838\u201343.","journal-title":"Diabetes Care"},{"issue":"8","key":"2237_CR16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/ICO.0b013e3180de493f","volume":"26","author":"T Darwish","year":"2007","unstructured":"Darwish T, Brahma A, Efron N, O\u2019Donnell C. Subbasal nerve regeneration after penetrating keratoplasty. Cornea. 2007;26(8):935\u201340.","journal-title":"Cornea"},{"issue":"1","key":"2237_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jtos.2016.09.004","volume":"15","author":"A Cruzat","year":"2017","unstructured":"Cruzat A, Qazi Y, Hamrah P. In vivo confocal microscopy of corneal nerves in health and disease. Ocul Surf. 2017;15(1):15\u201347.","journal-title":"Ocul Surf"},{"issue":"1","key":"2237_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/OPX.0000000000001158","volume":"95","author":"Y Pan","year":"2018","unstructured":"Pan Y, Liu F, Qi X, Hu Y, Xu F, Jia H. Nerve growth factor changes and corneal nerve repair after keratoplasty. Optom Vis Sci. 2018;95(1):27\u201331.","journal-title":"Optom Vis Sci"},{"issue":"8","key":"2237_CR19","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.4103\/1673-5374.213534","volume":"12","author":"M Sacchetti","year":"2017","unstructured":"Sacchetti M, Lambiase A. Neurotrophic factors and corneal nerve regeneration. Neural Regen Res. 2017;12(8):1220\u20134.","journal-title":"Neural Regen Res"},{"key":"2237_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/ICB.0000000000000832","volume":"15","author":"RA Kurt","year":"2018","unstructured":"Kurt RA, Sonmez B, Kapran Z. Neurotrophic keratopathy after retinal detachment surgery combined with endolaser photocoagulation. Retin Cases Brief Rep. 2018;15:479.","journal-title":"Retin Cases Brief Rep."},{"key":"2237_CR21","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/srep03419","volume":"3","author":"Y Ogawa","year":"2013","unstructured":"Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI, et al. International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I). Sci Rep. 2013;3:3419.","journal-title":"Sci Rep"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02237-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02237-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02237-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:27:57Z","timestamp":1645468077000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02237-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2237"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02237-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"2 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective, observational case series was carried out at the Eye Clinic of the University of Verona in compliance with the tenets of the Declaration of Helsinki. Institutional Ethics committee of Verona and Rovigo approval (protocol n. 73518) and written informed consent from all participants were obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of this study was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests, either financial or non-financial, that could be perceived as prejudicing the impartiality of the research reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}